GelSana Therapeutics, Inc.

CIK 2002665 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for GelSana Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 6, 2026D/A0002002665-26-000003
Aug 14, 2024D/A0002002665-24-000001
Dec 4, 2023D0002002665-23-000001